Conference Call Scheduled for July 22, 2008 at 11:00 am EASTERN
DUBLIN, Ireland, July 15 /PRNewswire-FirstCall/ -- Trinity Biotech plc
(Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products
for the point-of-care and clinical laboratory markets, will report
financial results for the second quarter of fiscal year 2008 on Tuesday,
July 22, 2008. The Company has scheduled a conference call for that same
day, Tuesday, July 22, 2008, at 11:00am EDT (4:00pm BST) to discuss the
results of the quarter.
Interested parties can access the call by dialing:
A simultaneous webcast of the call can be accessed at:
A replay of the call can be accessed until July 25, 2008 by dialing:
Conference ID #: 56210288
The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=50024
About Trinity Biotech plc
Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires, manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.
For further information please see the company's website:
Ms. Niamh Long Joe Diaz, Joe Dorame and Robert Blum
Trinity Biotech plc Lytham Partners, LLC
Investor Relations Officer 602-889-7900
|SOURCE Trinity Biotech plc|
Copyright©2008 PR Newswire.
All rights reserved